- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 233/01 - Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
Patent holdings for IPC class C07C 233/01
Total number of patents in this class: 79
10-year publication summary
|
5
|
7
|
2
|
10
|
2
|
4
|
1
|
4
|
2
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| New York Blood Center, Inc. | 167 |
6 |
| National Institute of Biological Sciences, Beijing | 100 |
5 |
| Eli Lilly and Company | 3888 |
3 |
| Forschungsverbund Berlin e.V. | 194 |
3 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2871 |
3 |
| Novartis AG | 10725 |
2 |
| Baker Hughes Incorporated | 5248 |
2 |
| ChemTreat, Inc. | 235 |
2 |
| Ishihara Sangyo Kaisha, Ltd. | 662 |
2 |
| Orchid Research Laboratories Limited | 22 |
2 |
| University College Cardiff Consultants Limited | 271 |
2 |
| Institut Pasteur de Montevideo | 32 |
2 |
| AstraZeneca AB | 2895 |
1 |
| AstraZeneca UK Limited | 628 |
1 |
| Hyundai Motor Company | 22315 |
1 |
| The Johns Hopkins University | 5714 |
1 |
| Agency for Science, Technology and Research | 3646 |
1 |
| Anhui Medical University | 20 |
1 |
| Anhui New Star Pharmaceutical Development Co., Ltd. | 13 |
1 |
| Assia Chemical Industries Ltd. | 188 |
1 |
| Other owners | 37 |